Inflammation Research

, Volume 62, Issue 2, pp 213–218

The effects of various doses of bacterial lipopolysaccharide on the expression of CD63 and the release of histamine by basophils of atopic and non-atopic patients

  • E. Gyimesi
  • F. Gönczi
  • M. Szilasi
  • G. Pál
  • S. Baráth
  • S. Sipka
Original Research Paper

Abstract

Objective

We tested the effect of various doses of bacterial lipopolysaccharide (LPS, endotoxin) on the expression of CD63 and the in vitro release of histamine by basophils stimulated with ragweed allergen in patients with or without ragweed and mite allergies.

Methods

The peripheral blood of 11 patients with ragweed allergy, 10 patients with mite allergy and 14 control patients was incubated with ragweed allergen extract following pretreatment with varying doses of LPS. The expression of CD63 in basophils was measured by flow cytometry, and the release of histamine was determined by ELISA.

Results

In the samples of patients with ragweed allergy that were exposed to specific allergen, only high doses of LPS significantly elevated the expression of CD63 (200 ng/ml; 1,000 EU/ml) and the release of histamine (2,000 ng/ml; 10,000 EU/ml). There was no effect of LPS in any other cases.

Conclusions

Bacterial LPS (endotoxin) concentrations higher than 200 ng/ml (1,000 EU/ml), which rarely occurs in nature, could only activate the basophils from atopic patients whilst in the presence of the specific allergen. Thus, the restoration of the urban, “microbe-poor” milieu with endotoxin (as LPS) can be a promising and harmless approach for allergy prevention.

Keywords

Bacterial lipopolysaccharide (endotoxin) CD63 Histamine Atopic allergy 

References

  1. 1.
    Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675–80.PubMedCrossRefGoogle Scholar
  2. 2.
    Gereda JE, Leung DY, Thatayatikom A, Streib JE, Price MR, Klinnert MD, et al. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitization in infants at high risk of asthma. Lancet. 2000;355:1680–3.PubMedCrossRefGoogle Scholar
  3. 3.
    Braun-Fahrländer C, Riedler J, Herz U, Eder W, Waser M, Grize L, et al. Allergy and endotoxin study team: environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med. 2002;347:869–77.PubMedCrossRefGoogle Scholar
  4. 4.
    Gehring U, Bischof W, Fahlbush B, Wichman H, Heinrich J. House dust endotoxin and allergic sensitization in children. Am J Respir Crit Care Med. 2002;166:939–44.PubMedCrossRefGoogle Scholar
  5. 5.
    Van Strien RT, Engel R, Holt O, Bufe A, Eder W, Waser M, et al. ALEX study team: microbial exposure of rural school children, as assessed by levels of N-acetyl-muramic acid in mattress dust, and its association with respiratory health. J Allergy Clin Immunol. 2004;113:860–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Gehring U, Bischof W, Schlenvoight G, Richter K, Fahlbush B, Wischmann HE, et al. INGA study group: exposure to house dust endotoxin and allergic sensitization in adults. Allergy. 2004;59:946–52.PubMedCrossRefGoogle Scholar
  7. 7.
    Park JH, Gold DR, Spiegelman DL, Burge HA, Milton DK. House dust endotoxin and repeated wheeze in the first year of life. Am J Respir Crit Care Med. 2001;163:322–8.PubMedGoogle Scholar
  8. 8.
    Rizzo MC, Naspitz CK, Fernandez-Caldas E, Lockey RF, Mimica I, Sole D. Pediatr Allergy Immunol. 1997;8:121–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Norn S, Baek L, Jensen C, Stahl Skov P, Permin H, Jarlov JO, et al. Influence of bacterial endotoxins on basophil histamine release. Allergy. 1986;41:125–30.PubMedCrossRefGoogle Scholar
  10. 10.
    Clementsen P, Norn S, Kristensen KS, Bach-Mostensen N, Koch C, Permin H. Bacteria and endotoxin enhance basophil histamine release and potentiation is abolished by carbohydrates. Allergy. 1990;45:402–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Sheehan WJ, Hoffman EB, Fu C, Baxi SN, Bailey A, King EM, et al. Endotoxin exposure in inner-city schools and homes of children with asthma. Ann Allergy Asthma Immunol. 2012;108:418–22.PubMedCrossRefGoogle Scholar
  12. 12.
    Gyimesi E, Sipka S, Dankó K, Kiss E, Hídvégi B, Gál M, et al. Basophil CD63 expression assay on highly sensitized atopic donor leukocytes—a useful method in chronic autoimmune urticaria: british. J Dermatol. 2004;151:388–96.CrossRefGoogle Scholar
  13. 13.
    Ehlers S, Kaufmann SH. In: 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: lifestyle changes affecting the host-environment interface. Clin Exp Immunol. 2010;160:10–4.Google Scholar
  14. 14.
    Matricardi PM, Bjorksten B, Bonini S, Bousquet J, Djukanovic R, Dreborg S, et al. EAACI task force 7: microbial products in allergy prevention and therapy. Allergy. 2003;58:461–71.PubMedCrossRefGoogle Scholar
  15. 15.
    De Weck AL, Sanz ML, Gamboa PM, Aberer W, Bienvenu J, Blanca M, et al. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. Int Arch Allergy Immunol II. 2008;146:177–89.CrossRefGoogle Scholar
  16. 16.
    Chirumbolo S, Vella A, Ortolani R, De Gironcoli M, Solero P, Tridente G, et al. Differential response of human basophil activation markers: a multiparameter flow cytometry approach. Clin Mol Allergy. 2008;6:12.PubMedCrossRefGoogle Scholar
  17. 17.
    Ebo DG, Sainte-Laudy J, Bridts CH, Mertens CH, Hagendorens MM, Schuerwegh AJ, et al. Flow-assisted allergy diagnosis: current applications and future perspectives. Allergy. 2006;61:1028–39.PubMedCrossRefGoogle Scholar
  18. 18.
    Knol EF, Mul FP, Jansen H, Calafat J, Roos D. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol. 1991;88:328–38.PubMedCrossRefGoogle Scholar
  19. 19.
    Hennesrsdorf F, Florian S, Jakob A, Baumgartner K, Somneck K, Nordheim A, et al. Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation. Cell Res. 2005;15:325–35.CrossRefGoogle Scholar
  20. 20.
    MacGlashan D. Expression of CD203c and CD63 in basophils: relationship to differential regulation of piecmeal and anaphylactic degranulation processes. Clin Exp Allergy. 2010;201(40):1365–77.CrossRefGoogle Scholar
  21. 21.
    Mendy A, Gasana J, Vieira ER, Forno E, Patel J, Kadam P, et al. Endotoxin exposure and childhood wheeze and asthma: a meta-analysis of observational studies. J Asthma. 2011;48:685–93.PubMedCrossRefGoogle Scholar
  22. 22.
    Chang AB, Peake J, McElrea MS (2008) Anti-histamines for prolonged non-specific cough in children. Cochrane Database Syst Rev 16(2): CD005604.Google Scholar
  23. 23.
    Ngamphaiboon J, Wirawarn Z, Thongkaew T. Prevention of recurrent wheezing in young children by loratidine compared with ketotifen. J Med Assoc Thai. 2009;92:351–5.PubMedGoogle Scholar
  24. 24.
    Rennie DC, Lawson JA, Senthilselvan A, Wiltson PJ, Dosman A. Domestic endotoxin exposure and asthma in children: epidemiological studies. Front Biosci. 2012;4:56–73.Google Scholar
  25. 25.
    Senthilselvan A, Dosman JA, Chénard L, Bruch LH, Predicala BZ, Sorowski R, et al. Toll-like receptor 4 variants reduce airway response in human subjects at high endotoxin levels in a swine facility. J Allergy Clin Immunol. 2009;123:1034–40.PubMedCrossRefGoogle Scholar
  26. 26.
    Park JH, Spiegelman DL, Burge HA, Gold DR, Chew GL, Milton DK. Longitudinal study of dust and airborne endotoxin in the home. Environ Health Perspect. 2000;108:1023–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Abbing-Karahapopian V, van der Gugten AC, van der Ent CK, Uiterwaal C, de Jongh M, Oldenwening M, et al. Effect of endotoxin and allergens on neonatal lung function and infancy respiratory symtoms and eczema. Pediatr Allergy Immunol. 2012;5:448–55.CrossRefGoogle Scholar
  28. 28.
    Basisnas I, Schlünssen V, Heederik D, Sigsgaard T, Smit LA, Samadi S, et al. Sensitisation to common allergens and respiratory symptoms in endotoxin exposed workers: a pooled analysis. Occup Environ Med. 2012;69:99–106.CrossRefGoogle Scholar
  29. 29.
    Babolewska E, Witczak P, Pietrzak A, Brzezinska-Blaszczyk E. Different potency of bacterial antigens TLR2 and TLR4 ligands in stimulating mature mast cells to cyteinyl leukotriene synthesis. Microbiol Immunol. 2012;56:183–90.PubMedCrossRefGoogle Scholar
  30. 30.
    Brekke OL, Christiansen D, Fure H, Fung M, Mollnes TE. The role of complement 3 opsonization, C5a receptor, and CD14 in E.coli-induced up regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. J Leukoc Biol. 2007;81:1404–13.PubMedCrossRefGoogle Scholar
  31. 31.
    Guan W, Zheng J, Gao Y, Jiang C, An J, Yu X, et al. Leukotriene D4 bronchial provocation test: methodology and diagnostic value. Curr Med Res. 2002;28:797–803.CrossRefGoogle Scholar
  32. 32.
    Hrncir T, Stepankova R, Kozakova H, Hudcovic T, Tlaskolava-Hogenova H. Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol. 2008;9:65–72.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Basel 2012

Authors and Affiliations

  • E. Gyimesi
    • 1
  • F. Gönczi
    • 2
  • M. Szilasi
    • 3
  • G. Pál
    • 1
  • S. Baráth
    • 1
  • S. Sipka
    • 1
  1. 1.Division of Clinical Immunology, Department of Medicine, Medical and Health Science CentreUniversity of DebrecenDebrecenHungary
  2. 2.County HospitalDebrecenHungary
  3. 3.Department of Pulmonology, Medical and Health Sciences CenterUniversity of DebrecenDebrecenHungary

Personalised recommendations